Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogues of TQX-173

被引:43
作者
Catarzi, D
Colotta, V
Varano, F
Filacchioni, G
Galli, A
Costagli, C
Carlà, V
机构
[1] Univ Florence, Dipartimento Sci Farmaceut, I-50121 Florence, Italy
[2] Univ Florence, Dept Preclin & Clin Pharmacol, I-50134 Florence, Italy
关键词
D O I
10.1021/jm010862q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A seires of 4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogues of TQX-173 (1b), bearing different nitrogen-containing heterocycles at position-8, were synthesized as AMPA receptor antagonists. All the reported compounds were also biologically evaluated for their binding at glycine/NMDA and KA receptors to better assess their selectivity toward the AMPA receptor. Structure-activity relationships (SAR) on these TQX derivatives have evidenced that the precise positioning of the nitrogen atoms and the specific electronic topography of the 8-heteroaromatic ring are both important for the anchoring to the AMPA receptor. In fact, it has been well-established that the presence of a N-3-nitrogen-containing heterocycle at position-8 of the TQX framework is an essential feature for potent and selective AMPA receptor antagonists. Functional antagonism at both AMPA receptor and NMDA receptor-ion channel complex was evaluated by assessing the ability of some selected compounds to inhibit depolarization induced by 5 muM AMPA or NMDA in mouse cortical wedge preparations.
引用
收藏
页码:3157 / 3165
页数:9
相关论文
共 29 条
[1]   Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia [J].
Arias, RL ;
Tasse, JRP ;
Bowlby, MR .
BRAIN RESEARCH, 1999, 816 (02) :299-308
[2]   Mechanisms for activation and antagonism of an AMPA-Sensitive glutamate receptor: Crystal structures of the GluR2 ligand binding core [J].
Armstrong, N ;
Gouaux, E .
NEURON, 2000, 28 (01) :165-181
[3]  
Bigge CF, 1996, CURR PHARM DESIGN, V2, P397
[4]   AMPA receptor agonists, antagonists and modulators: their potential for clinical utility [J].
Bigge, CF ;
Nikam, SS .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (10) :1099-1114
[5]   Ligands for glutamate receptors:: Design and therapeutic prospects [J].
Bräuner-Osborne, H ;
Egebjerg, J ;
Nielsen, EO ;
Madsen, U ;
Krogsgaard-Larsen, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) :2609-2645
[6]   4,5-dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones:: Excitatory amino acid antagonists with combined glycine NMDA and AMPA receptor affinity [J].
Catarzi, D ;
Colotta, V ;
Varano, F ;
Cecchi, L ;
Filacchioni, G ;
Galli, A ;
Costagli, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (13) :2478-2484
[7]   7-chloro-4,5-dihydro-8-(1,2,4-triazol-4-yl)4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates as novel highly selective AMPA receptor antagonists [J].
Catarzi, D ;
Colotta, V ;
Varano, F ;
Cecchi, L ;
Filacchioni, G ;
Galli, A ;
Costagli, C ;
Carlà, V .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (21) :3824-3826
[8]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[9]   AMPA receptor antagonists [J].
Chimirri, A ;
Gitto, R ;
Zappalà, M .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (05) :557-570
[10]   Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazoline-2,4-diones as glycine-NMDA antagonists: A pharmacophore model based approach [J].
Colotta, V ;
Catarzi, D ;
Varano, F ;
Cecchi, L ;
Filacchioni, G ;
Galli, A ;
Costagli, C .
ARCHIV DER PHARMAZIE, 1997, 330 (05) :129-134